Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer.

MLA

Dean, Sarah J. R., et al. “Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer.” American Journal of Clinical Pathology, vol. 141, no. 3, Mar. 2014, pp. 323–33. EBSCOhost, https://doi.org/10.1309/AJCPR11DEAYPTUSL.

APA

Dean, S. J. R., Perks, C. M., Holly, J. M. P., Bhoo-Pathy, N., Lai-Meng Looi, Taib Mohammed, N. A., Koobotse, M. O., Soo-Hwang Teo, Kein-Seong Mun, Cheng-Har Yip, & Rhodes, A. (2014). Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer. American Journal of Clinical Pathology, 141(3), 323–333. https://doi.org/10.1309/AJCPR11DEAYPTUSL

Chicago

Dean, Sarah J. R., Claire M. Perks, Jeff M. P. Holly, Nirmala Bhoo-Pathy, Lai-Meng Looi, Nur Aishah Taib Mohammed, Moses O. Koobotse, et al. 2014. “Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer.” American Journal of Clinical Pathology 141 (3): 323–33. doi:10.1309/AJCPR11DEAYPTUSL.